BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 21981886)

  • 1. [Cannabis withdrawal syndrome in patients with cannabis dependence only, and in patients with cannabis and opioid dependence].
    Vorspan F; Guillem E; Bloch V; Bellais L; Sicot R; Noble F; Lepine JP; Gorelick DA
    Encephale; 2011 Sep; 37(4):266-72. PubMed ID: 21981886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the history of a marijuana withdrawal syndrome in a large population.
    Wiesbeck GA; Schuckit MA; Kalmijn JA; Tipp JE; Bucholz KK; Smith TL
    Addiction; 1996 Oct; 91(10):1469-78. PubMed ID: 8917915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Motivations for cannabis cessation, coping and adaptation strategies, and perceived benefits: impact on cannabis use relapse and abstinence].
    Chauchard E; Septfons A; Chabrol H
    Encephale; 2013 Dec; 39(6):385-92. PubMed ID: 23928064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective assessment of cannabis withdrawal in adolescents with cannabis dependence: a pilot study.
    Milin R; Manion I; Dare G; Walker S
    J Am Acad Child Adolesc Psychiatry; 2008 Feb; 47(2):174-179. PubMed ID: 18176332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low efficacy of non-opioid drugs in opioid withdrawal symptoms.
    Hermann D; Klages E; Welzel H; Mann K; Croissant B
    Addict Biol; 2005 Jun; 10(2):165-9. PubMed ID: 16191669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis withdrawal severity and short-term course among cannabis-dependent adolescent and young adult inpatients.
    Preuss UW; Watzke AB; Zimmermann J; Wong JW; Schmidt CO
    Drug Alcohol Depend; 2010 Jan; 106(2-3):133-41. PubMed ID: 19783382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis withdrawal in patients with and without opioid dependence.
    Chauchard E; Goncharov O; Krupitsky E; Gorelick DA
    Subst Abus; 2014; 35(3):230-4. PubMed ID: 24745656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of dependence and motivation for treatment: comparison of marijuana- and cocaine-dependent treatment seekers.
    Levin FR; Brooks DJ; Bisaga A; Raby W; Rubin E; Aharonovich E; Nunes EV
    J Addict Dis; 2006; 25(1):33-41. PubMed ID: 16597571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.
    Allsop DJ; Copeland J; Lintzeris N; Dunlop AJ; Montebello M; Sadler C; Rivas GR; Holland RM; Muhleisen P; Norberg MM; Booth J; McGregor IS
    JAMA Psychiatry; 2014 Mar; 71(3):281-91. PubMed ID: 24430917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study.
    Winstock AR; Lea T; Copeland J
    J Psychopharmacol; 2009 Jan; 23(1):84-93. PubMed ID: 18515451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users.
    Lubman D; Koutsogiannis Z; Kronborg I
    Drug Alcohol Rev; 2003 Dec; 22(4):433-6. PubMed ID: 14660133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms.
    Budney AJ; Vandrey RG; Hughes JR; Moore BA; Bahrenburg B
    Drug Alcohol Depend; 2007 Jan; 86(1):22-9. PubMed ID: 16769180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopathology among cannabis-dependent treatment seekers and association with later substance abuse treatment.
    Arendt M; Rosenberg R; Foldager L; Perto G; Munk-Jørgensen P
    J Subst Abuse Treat; 2007 Mar; 32(2):113-9. PubMed ID: 17306720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The opioids: abuse liability and treatments for dependence.
    Ternes JW; O'Brien CP
    Adv Alcohol Subst Abuse; 1990; 9(1-2):27-45. PubMed ID: 2198785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence for reduction of opioid-withdrawal symptoms by cannabis smoking during a methadone dose taper.
    Epstein DH; Preston KL
    Am J Addict; 2015 Jun; 24(4):323-8. PubMed ID: 25846329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbid posttraumatic stress disorder and opiate addiction: a literature review.
    Fareed A; Eilender P; Haber M; Bremner J; Whitfield N; Drexler K
    J Addict Dis; 2013; 32(2):168-79. PubMed ID: 23815424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis withdrawal among non-treatment-seeking adult cannabis users.
    Copersino ML; Boyd SJ; Tashkin DP; Huestis MA; Heishman SJ; Dermand JC; Simmons MS; Gorelick DA
    Am J Addict; 2006; 15(1):8-14. PubMed ID: 16449088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pregabalin for the reduction of opiate withdrawal symptoms].
    Kämmerer N; Lemenager T; Grosshans M; Kiefer F; Hermann D
    Psychiatr Prax; 2012 Oct; 39(7):351-2. PubMed ID: 22689280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.